Medical Oncologist, Dermatologist and Director of the Center for Merkel Cell Carcinoma at the Mass General Cancer Center
Joined December 2019
- Tweets385
- Following487
- Followers488
- Likes749
David M. Miller MD, PhD, FAAD retweeted
There’s still time! Don’t miss the latest CME activity on the role of immunotherapy in nonmelanoma skin cancer. #MedEd #CME #MedTwitter #Skin #DermTwitter
ow.ly/TCtM50OYxwz
David M. Miller MD, PhD, FAAD retweeted
Explore Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer with leading experts Dr. Miller @TheMillerLab and Dr.Patel!
Register now for Monday, June 26th at 7:00 PM ET: medlearninggroup.com/cme-pro…
#Virtual #CME #Immunotherapy #MedTwitter #MedLearningGroup
ALT Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer
David M. Miller MD, PhD, FAAD retweeted
Thx to Laura Ferris, Nikhi Khushalani, Kevin Emerick, Sonia Cohen, Sameer Gupta, Ryan Sullivan, @bosques12, @EmilyKimMed, @BhatiaS_MD, @MunTheLoon & @TheMillerLab for another great Journal Club discussion of the @USPSTF recs re: skin cancer screening
jamanetwork.com/journals/jam…
David M. Miller MD, PhD, FAAD retweeted
I'm excited to live stream #rstats #shiny app dev for @r_medicine 2023! We'll explore a licorice study with:
🦏 {rhino} @appsilon
🔍 Summary tables {Tplyr} @AtorusR & {reactable}
⭐️ Dashboard UI from {bslib} @cpsievert
📆 June 8 (1 PM EDT/7 PM CEST)
📡 twitch.tv/rpodcast
David M. Miller MD, PhD, FAAD retweeted
David Miller & Sophia Shalhout with @MGHMedicine & @MassEyeAndEar, will be giving a session presentation on “StoryboardR: An R package and Shiny application designed to visualize real-world data from clinical patient registries” at #RMed2023. #Rstats ➡️ events.linuxfoundation.org/r…
ALT Below the R/Med logo there is text "StoryboardR" and "David Michael Miller, Oncologist at Massachusetts General Hospital" and ""Sophia Z. Shalhout Principal Investigator, Mass Eye and Ear/Harvard Medical School"
David M. Miller MD, PhD, FAAD retweeted
🎉 The excitement is building as we count down for our Complimentary Virtual CME/CNE Program on NMSC!
Join Dr. Miller @TheMillerLab and Dr. Patel TONIGHT at 7:30 PM EST!
Register Now: ow.ly/HZUo50OBUVO
#oncology #MedTwitter #VirtualEvent #CME #CNE #MedLearningGroup
ALT The Emerging Standard of Care: Immunotherapy in Non-Melanoma Skin Cancer
David M. Miller MD, PhD, FAAD retweeted
Experience our Complimentary Live Virtual CME/CNE Program featuring NMSC on Monday, 6/5, at 7:30 PM ET with Dr. Miller @TheMillerLab and Dr. Patel!
Register now: medlearninggroup.com/cme-pro…
#Immunotherapy #MedicalEducation #VirtualEvent #CME #CNE #MedLearningGroup
ALT The Emerging Standard of Care: Immunotherapy in Non-Melanoma Skin Cancer
David M. Miller MD, PhD, FAAD retweeted
Explore the latest melanoma therapies and the significant role of anti-LAG3 antibodies with Dr. Miller @TheMillerLab!
Learn more about this activity: ow.ly/13yc50Nu3fm
#SkinCancerAwareness #Melanoma #immunotherapy #CME #medicaleducation #medlearninggroup
ALT The ACTIVATE Initiative Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role
David M. Miller MD, PhD, FAAD retweeted
Does immune checkpoint inhibitor therapy increase the risk of cardiovascular events? Check out this "Perspectives On The Science" article in #JoCO (@CutaneousOnc ) from #SoCO members @TheMillerLab, @SophiaShalhout et al.
doi.org/10.59449/joco.…
#Cancer
David M. Miller MD, PhD, FAAD retweeted
Is there a connection between immunotherapy and cardiovascular events such as MI and stroke? Check out the latest Perspectives on the Science piece in #JoCO by @TheMillerLab, @sophiashalhout, et al.
doi.org/10.59449/joco.2023.0…
#Cancer #Immunotherapy
David M. Miller MD, PhD, FAAD retweeted
Fri June 9 keynote at R/Med 2023 from Jeff Leek of Fred Hutch Cancer Center, at 11 AM ET for the west coast. Jeff will start with Building the Fred Hutch DS Lab, w/a side quest on Non-profit DS training to solve the problems of economic opportunity deserts & diversity in DS
David M. Miller MD, PhD, FAAD retweeted
Shedding new light on the dark side of cancer immunotherapy - mechanisms of IRAEs. Just out in @ScienceTM, grateful for support from @UCLAHealth and @AmThyroidAssn and my collaborators @DoctorAngell @MaureenSuLab wix.to/yPSqMbG
David M. Miller MD, PhD, FAAD retweeted
Thanks @DrJustineCohen, @SophiaShalhout, @TheMillerLab, @HowardK39084949 and others for another superb SoCO research forum. Your insights, perspectives and experiences on the scientific review process were so valuable and helpful.
David M. Miller MD, PhD, FAAD retweeted
Is triplet therapy in advanced melanoma ready for prime time? Check out this "Perspectives On The Science" article in #JoCO (@CutaneousOnc) from #SoCO members @TheMillerLab, @bruindoctor et al.
doi.org/10.59449/joco.2023.0…
#melanoma #Cancer
David M. Miller MD, PhD, FAAD retweeted
What's the role of nicotinamide in chemoprevention for solid organ transplant recipients? Check out this "Perspectives On The Science" article in #JoCO (@CutaneousOnc ) from #SoCO members @HowardK39084949, @TheMillerLab, @bruindoctor & @SophiaShalhout .
doi.org/10.59449/joco.2023.0…
David M. Miller MD, PhD, FAAD retweeted
Join us at our Complimentary ACTIVATE TeleECHO Series today at 2:00 PM ET, 1:00 PM CST, 12:00 PM MDT, and 11:00 AM PST!
Register Now: ow.ly/H1Nm50NJCa1
More Dates & Times: ow.ly/Tyu450NJC9W
#skincancer #Melanoma #webinar #medlearninggroup #healthcareprofessional
ALT ACTIVATE Initiative: Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role
David M. Miller MD, PhD, FAAD retweeted
May is Melanoma and Skin Cancer Awareness Month!
Join us in raising awareness and staying informed with our NEW Activate Podcast Series with Dr. Miller @TheMillerLab!
Listen Now: ow.ly/eHQr50NQz6h
#skincancerawareness #melanoma #Patient #podcast #CME #Medlearninggroup
ALT ACTIVATE Initiative: Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role
David M. Miller MD, PhD, FAAD retweeted
Tomorrow's SoCO Journal Club is featuring @MGHHeartHealth's Dr. Neilan's article describing the association of immune checkpoint inhibitors and cardiovascular events. Should make for a great discussion.
doi.org/10.1161/CIRCULATIONA…
#MGH #SocietyofCutaneousOncology
@CircAHA
David M. Miller MD, PhD, FAAD retweeted
In this Perspectives on the Science piece, the authors reflect on the impact of the recently reported SWOG S1801 trial, published in @NEJM.
doi.org/10.59449/joco.2023.0…
@Serenavilasi @TheMillerLab @HowardK39084949 @SophiaShalhout @SocCutaneousOnc @bruindoctor
#Melanoma
David M. Miller MD, PhD, FAAD retweeted
In this Perspectives on the Science piece, the authors reflect on the impact of the recent @TheLancetOncol article that provides interim results from IMspire150.
doi.org/10.59449/joco.2023.0…
@TheMillerLab @bruindoctor
#Melanoma #CancerResearch